![IJMS | Free Full-Text | Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells IJMS | Free Full-Text | Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells](https://pub.mdpi-res.com/ijms/ijms-17-00531/article_deploy/html/images/ijms-17-00531-g008.png?1461812953)
IJMS | Free Full-Text | Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells
![Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update - Cytotherapy Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update - Cytotherapy](https://www.isct-cytotherapy.org/cms/attachment/2003105108/2012310923/gr1.jpg)
Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update - Cytotherapy
![Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/277486ae-370f-4b4c-8802-b34f748385a3/301ga1.jpg)
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology
![Imatinib Line, Mechanism Of Action, Targeted Therapy, Abl, Pharmaceutical Drug, Enzyme Inhibitor, Philadelphia Chromosome, Acute Lymphoblastic Leukemia, Imatinib, Mechanism Of Action, Targeted Therapy png | PNGWing Imatinib Line, Mechanism Of Action, Targeted Therapy, Abl, Pharmaceutical Drug, Enzyme Inhibitor, Philadelphia Chromosome, Acute Lymphoblastic Leukemia, Imatinib, Mechanism Of Action, Targeted Therapy png | PNGWing](https://w1.pngwing.com/pngs/785/436/png-transparent-imatinib-line-mechanism-of-action-targeted-therapy-abl-pharmaceutical-drug-enzyme-inhibitor-philadelphia-chromosome-acute-lymphoblastic-leukemia.png)
Imatinib Line, Mechanism Of Action, Targeted Therapy, Abl, Pharmaceutical Drug, Enzyme Inhibitor, Philadelphia Chromosome, Acute Lymphoblastic Leukemia, Imatinib, Mechanism Of Action, Targeted Therapy png | PNGWing
![Figure 2, Schematic model for the mechanism of action of Gleevec (imatinib) - Mechanistic Evidence in Evidence-Based Medicine: A Conceptual Framework - NCBI Bookshelf Figure 2, Schematic model for the mechanism of action of Gleevec (imatinib) - Mechanistic Evidence in Evidence-Based Medicine: A Conceptual Framework - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK154588/bin/resultsf2.jpg)
Figure 2, Schematic model for the mechanism of action of Gleevec (imatinib) - Mechanistic Evidence in Evidence-Based Medicine: A Conceptual Framework - NCBI Bookshelf
![Mode of action of imatinib (Gleevec) in CML: Occupation of the tyrosine... | Download Scientific Diagram Mode of action of imatinib (Gleevec) in CML: Occupation of the tyrosine... | Download Scientific Diagram](https://www.researchgate.net/publication/353426974/figure/fig1/AS:1048914337730561@1627092074985/Mode-of-action-of-imatinib-Gleevec-in-CML-Occupation-of-the-tyrosine-kinase-pocket-of.png)